The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-01), Accendra Health's 9-Day RSI is 66.01.
The industry rank for Accendra Health's 9-Day RSI or its related term are showing as below:
ACH's 9-Day RSI is ranked worse than 87.9% of 124
companies
in the Medical Distribution industry
Industry Median: 45.82
vs ACH: 66.01
Accendra Health (NYSE:ACH) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Accendra Health 9-Day RSI Related Terms
ACH vs FOCL, YI, COSM: 9-Day RSI Comparison
For the Medical Distribution subindustry, Accendra Health's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health 9-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Accendra Health's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a 9-Day RSI of 66.01 as of Jul. 01, 2026. According to the industry distribution chart, Accendra Health ranks #109 out of 124 companies in the Medical Distribution industry, placing it in the top 87.9%.
Is Accendra Health's 9-Day RSI too high?
Accendra Health's current 9-Day RSI is 66.01. The Medical Distribution industry median 9-Day RSI is 45.82. Accendra Health's value of 66.01 is 44.1% above this industry median. Based on the distribution chart, Accendra Health ranks #109 out of 124 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Accendra Health has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's 9-Day RSI compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #109 out of 124 companies for 9-Day RSI. This places Accendra Health in the lower half of its industry. The industry median 9-Day RSI is 45.82. Accendra Health's value of 66.01 is 44.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Distribution company?
The median 9-Day RSI among Medical Distribution companies is 45.82, based on 124 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current 9-Day RSI of 66.01 is 44.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median 9-Day RSI is 45.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current 9-Day RSI is 66.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.56 — trading 29.1% below its estimated fair value. The current 9-Day RSI is 66.01 and 44.1% above the Medical Distribution industry median of 45.82. Accendra Health's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Accendra Health (ACH), the current 9-Day RSI is 66.01 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.56 is trading 29.1% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
9-Day RSI: 66.01
GF Value™: $5.02 vs. price of $3.56 (29.1% below fair value)
Industry Position: 44.1% above the Medical Distribution median (#109 of 124)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
61GF Score
Get the complete analysis for ACH
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 